The personalized cancer vaccines global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Personalized Cancer Vaccines Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The personalized cancer vaccines market size has grown strongly in recent years. It will grow from $227.31 billion in 2023 to $242.29 billion in 2024 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to advancements in genomic research, development of targeted therapies, increased understanding of tumor immunology, progress in vaccine technology and growing clinical trial data supporting efficacy.
The personalized cancer vaccines market size is expected to see strong growth in the next few years. It will grow to $315.16 billion in 2028 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to advancements in precision medicine, increasing funding for cancer research, rising prevalence of cancer cases, improvements in genetic sequencing technologies and growing interest in personalized treatment options. Major trends in the forecast period include the integration of artificial intelligence in vaccine design, advances in multi-antigen and neoantigen-based vaccines, increased use of liquid biopsies for tumor monitoring, expansion of combination therapies, and greater focus on personalized treatment regimens.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/personalized-cancer-vaccines-global-market-report
Scope Of Personalized Cancer Vaccines Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Personalized Cancer Vaccines Market Overview
Market Drivers –
The increasing prevalence of cancer is expected to propel the growth of the personalized cancer vaccine market going forward. Cancer refers to a collection of diseases marked by abnormal cell growth that can spread to other parts of the body. The increasing prevalence of cancer is due to aging populations, lifestyle changes, environmental pollutants, genetic predispositions, and improved diagnostic techniques. Personalized cancer vaccines help prevent the increasing prevalence of cancer by targeting specific tumor antigens unique to each patient, enhancing the immune system’s ability to recognize and destroy cancer cells. For instance, in July 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, in Australia the number of cancer cases diagnosed increased from 160,570 in 2022 to 164,694 in 2023, reflecting a notable rise over the year. Therefore, the increasing prevalence of cancer is driving the growth of the personalized cancer vaccine market.
Market Trends –
Major companies operating in the personalized cancer vaccine market are focused on developing advanced therapeutic solutions, such as personalized immunotherapy, to enhance precision in treating specific cancer mutations. Personalized immunotherapy solutions are customized treatments designed to use a patient’s unique genetic and tumor characteristics to improve immune system responses against cancer. For instance, in August 2024, UCLA Health, a US-based healthcare organization, launched a first-of-its-kind clinical trial to evaluate the safety and effectiveness of a cancer vaccine. The vaccine developed at UCLA leverages a personalized immunotherapy approach that targets the H3 G34 mutation in diffuse hemispheric gliomas, a highly aggressive brain tumor often found in adolescents and young adults. It uniquely utilizes dendritic cells to activate the immune system against the specific RNA disruptions caused by this mutation. The approach, which has shown promise in treating other cancers, aims to improve outcomes for patients who typically face limited treatment options and short survival times.
The personalized cancer vaccines market covered in this report is segmented –
1) By Treatment Type: Preventive Cancer Vaccines, Therapeutic Cancer Vaccines
2) By Cancer Type: Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Prostate Cancer, Cervical Cancer, Glioblastoma
3) By Mechanism Of Action: Tumor Associated Antigens (TAAs), Tumor Specific Antigens (TSAs), Somatic Mutations In Cancer Pharmacogenomics, Pharmacogenomics Towards Genomic Polymorphism, Other Mechanisms Of Action
4) By Route Of Administration: Injectables, Other Routes Of Administration
5) By End Use: Hospitals, Clinic, Other End Users
Get an inside scoop of the personalized cancer vaccines market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=19136&type=smp
Regional Insights –
North America was the largest region in the personalized cancer vaccines market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized cancer vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies –
Major companies operating in the personalized cancer vaccines market are Merck & Co Inc., GlaxoSmithKline Plc, NEC Corporation, Moderna Inc., Catalent Inc., UCLA Health, Genetech Inc., NHS England, CureVac AG, Personalis Inc., Achilles Therapeutics Plc, Healio, Moffitt Corporation, BioPharma APAC, Celebrity Angels, EpiVax Therapeutics Inc., Evaxion Biotech AS, Geneos Therapeutics Inc., IFL Sciense, ISA Pharmaceuticals BV, Oxford Global, Kintara Therapeutics, VAXIMM Gmbh
Table of Contents
1. Executive Summary
2. Personalized Cancer Vaccines Market Report Structure
3. Personalized Cancer Vaccines Market Trends And Strategies
4. Personalized Cancer Vaccines Market – Macro Economic Scenario
5. Personalized Cancer Vaccines Market Size And Growth
…..
27. Personalized Cancer Vaccines Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
